<DOC>
	<DOCNO>NCT00654953</DOCNO>
	<brief_summary>To examine clinical efficacy sertraline ( 200 mg/day ) alone sertraline combination gabapentin . The purpose study examine whether antidepressant sertraline alone combine gabapentin delay time relapse relative placebo recently abstinent cocaine-dependent volunteer also depress . In addition , whether depressive symptom genetic factor influence treatment response study medication examine . Our hypothesis combine sertraline-gabapentin show longer period abstinence sertraline alone placebo .</brief_summary>
	<brief_title>Clinical Efficacy Sertraline Augmented With Gabapentin Depressed , Recently Abstinent Cocaine-dependent Humans</brief_title>
	<detailed_description>Subjects enrol 12-wk , double blind , randomize , placebo-controlled , clinical trial admit residential facility North Little Rock ( RCA-NLR ) randomize depressive symptom severity receive one following : sertraline alone ( 200 mg/day ) , sertraline ( 200 mg/day ) plus gabapentin ( 1200 mg/day ) , placebo . Subjects expect participate Substance Abuse Day Treatment Program reside RCA-NLR induct onto maintenance dose study medication ( week 1-2 ) . When participant transfer Outpatient Treatment Research Unit ( TRU ) start third week , continue receive study medication placebo ( week 3-12 ) expect participate weekly individual cognitive behavioral therapy . Supervised urines vital sign obtain thrice weekly ; self-reported adverse effect , mood drug use self-reports obtained weekly . At end 12 week , participant taper study medication five-day period , discharge study , refer appropriate treatment treatment/research program community interested .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1865 year old currently enrol treatment program subject must history cocaine use , street cocaine use history minimum 1 gram precede 3 month subject must meet DSMIV criterion cocaine dependence assess substance abuse section Structured Clinical Interview DSMIV ( SCID SCIDSAC ) subject must laboratory confirmation recent cocaine use ( positive urine cocaine benzoylecgonine ) month prior study entry subject must score least 15 Hamilton Depression Scale woman childbearing age must negative pregnancy test enroll study must agree monthly pregnancy test current diagnosis drug alcohol physical dependence ( cocaine tobacco ) ill health ( e.g. , major cardiovascular , renal , endocrine , hepatic disorder ) history schizophrenia , bipolar type I disorder present recent use overthecounter prescription psychoactive drug drug ( ) would expect major interaction drug test medical contraindication receive study medication ( e.g. , sertraline , use monoamine oxidase inhibitor within last two week ; significant history seizure ; significant history head trauma serious neurological disorder ) current suicidality psychosis Liver function test ( i.e. , liver enzymes ) great three time normal level pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>cocaine dependence</keyword>
	<keyword>depressive symptom</keyword>
	<keyword>relapse</keyword>
	<keyword>sertraline</keyword>
	<keyword>gabapentin</keyword>
</DOC>